NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Sohrab Shah

Genomic Disruption in High-Grade Serous Ovarian Carcinomas: Steady State or Continuous Drift?

Ovary

Norman F Boyd

Determinants of Breast Tissue Composition in Young Women

Breast

Denis C Guttridge

(PQD6) Muscle Stem Cells and Cancer Cachexia

Pancreas

Pathology

Norman Wolmark

NRG Oncology Network Group Operations Center

Stomach Corpus uteri Liver and intrahepatic bile ducts Colorectum Cervix uteri Brain, nervous system Oesophagus Bladder Pancreas Kidney, renal pelvis and ureter Breast Trachea, bronchus and lung Nasopharynx Ovary Prostate

Surgery / Surgical oncology Radiation Oncology

Dean E Brenner

Great Lakes/New England Clinical Validation Center

Colorectum Oesophagus

Alan Ashworth

The Development of First Time in Human (FTIH), Orally Bioavailable, Small Molecule Tankyrase Inhibitors for the Treatment of Cancer

Colorectum

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Stephen N Thibodeau

Prostate Cancer Susceptibility: The ICPCG Study

Prostate

Pathology

Melissa L Bondy

International Case Control Study of Malignant Glioma

Brain, nervous system